| TC | Stat | Stk | Ins | Fil | +d | +w | +m | +q | +h | +y | avg | 
|---|
| Filing Date | T Date | Ticker | Issuer | Inc | Sector | Ind | Industry | Owner | oSt | Rel | Title | T | TVal | Price | L | Qty | oc | Own | H | r2y | r1y | r6m | r3m | r6w | r3w | r7d | r3d | f1d | f1w | f1m | f3m | f6m | f1y | 
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3/18/24 17:40 | 9/10/19 | MIRM | Mirum Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Longpre Lara | CA | O | Chief De | P | 10 | 10.64 | 0 | 1 | 1 | 104 | D | ||||||||||||||
| 3/18/24 17:40 | 1/9/23 | MIRM | Mirum Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Longpre Lara | CA | O | Chief De | S | -21 | 20.62 | 0 | -1 | -1 | 104 | D | ||||||||||||||
| 2/5/24 21:10 | 2/2/24 | MIRM | Mirum Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Longpre Lara | CA | O | Chief De | S | -22 | 26.19 | 0 | -1 | -1 | 104 | D | ||||||||||||||
| 1/9/24 20:25 | 1/8/24 | MIRM | Mirum Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Longpre Lara | CA | O | Chief De | S | -29 | 28.04 | 0 | -1 | -1 | 105 | D | ||||||||||||||
| 7/5/23 19:37 | 7/3/23 | MIRM | Mirum Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Longpre Lara | CA | O | Chief De | S | -26 | 25.65 | 0 | -1 | -1 | 106 | D | ||||||||||||||
| 10/1/21 20:00 | 10/1/21 | MIRM | Mirum Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Longpre Lara | CA | O | Chief De | S | -19 | 19.26 | 0 | -1 | -1 | 84 | D | 
| D | Derivative transaction in filing (usually option exercise) | 
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price | 
| A | Amended filing | 
| E | Error detected in filing | 
| S - Sale | Sale of securities on an exchange or to another person | 
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) | 
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company | 
| P - Purchase | Purchase of securities on an exchange or from another person |